| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comprehensive repertoire of prokaryotic species identified in human beings
|
Hugon, Perrine
|
|
2015
|
15 |
10 |
p. 1211-1219
|
artikel
|
| 2 |
Antibiotics, copayments, and antimicrobial resistance: investment matters
|
Fitchett, Joseph R
|
|
2015
|
15 |
10 |
p. 1125-1127
|
artikel
|
| 3 |
Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trial
|
Margolis, David A
|
|
2015
|
15 |
10 |
p. 1145-1155
|
artikel
|
| 4 |
Challenges and key research questions for yaws eradication
|
Marks, Michael
|
|
2015
|
15 |
10 |
p. 1220-1225
|
artikel
|
| 5 |
Compassionate and optimum use of new tuberculosis drugs
|
Matteelli, Alberto
|
|
2015
|
15 |
10 |
p. 1131-1132
|
artikel
|
| 6 |
Compassionate and optimum use of new tuberculosis drugs
|
Reed, Caitlin
|
|
2015
|
15 |
10 |
p. 1131
|
artikel
|
| 7 |
Corrections
|
|
|
2015
|
15 |
10 |
p. 1130
|
artikel
|
| 8 |
Corrections
|
|
|
2015
|
15 |
10 |
p. 1130
|
artikel
|
| 9 |
Cryptococcosis by Cryptococcus gattii in China
|
Xue, Xinying
|
|
2015
|
15 |
10 |
p. 1135-1136
|
artikel
|
| 10 |
1,3-β-D-glucan in cryptococcal meningitis
|
Rhein, Joshua
|
|
2015
|
15 |
10 |
p. 1136-1137
|
artikel
|
| 11 |
Editors' note
|
|
|
2015
|
15 |
10 |
p. 1131
|
artikel
|
| 12 |
Evaluating Ebola vaccine trials: insights from simulation
|
Pulliam, Juliet R C
|
|
2015
|
15 |
10 |
p. 1134
|
artikel
|
| 13 |
Good news for billions of children who will receive IPV
|
Thompson, Kimberly M
|
|
2015
|
15 |
10 |
p. 1120-1122
|
artikel
|
| 14 |
Human sparganosis, a neglected food borne zoonosis
|
Liu, Quan
|
|
2015
|
15 |
10 |
p. 1226-1235
|
artikel
|
| 15 |
In celebration of the Jesuit's powder: a history of malaria treatment
|
Harrison, Natalie
|
|
2015
|
15 |
10 |
p. 1143
|
artikel
|
| 16 |
Infectious disease surveillance update
|
Zwizwai, Ruth
|
|
2015
|
15 |
10 |
p. 1141
|
artikel
|
| 17 |
MERS—an uncertain future
|
The Lancet Infectious Diseases,
|
|
2015
|
15 |
10 |
p. 1115
|
artikel
|
| 18 |
Mobile laboratories for Ebola and other pathogens
|
Mansuy, Jean Michel
|
|
2015
|
15 |
10 |
p. 1135
|
artikel
|
| 19 |
Myanmar given an international boost to eliminate malaria
|
Bagcchi, Sanjeet
|
|
2015
|
15 |
10 |
p. 1140-1141
|
artikel
|
| 20 |
Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial
|
Koh, Christopher
|
|
2015
|
15 |
10 |
p. 1167-1174
|
artikel
|
| 21 |
Out-of-pocket health expenditures and antimicrobial resistance in low-income and middle-income countries: an economic analysis
|
Alsan, Marcella
|
|
2015
|
15 |
10 |
p. 1203-1210
|
artikel
|
| 22 |
Overcoming barriers to polio eradication in conflict areas
|
Garon, Julie R
|
|
2015
|
15 |
10 |
p. 1122-1124
|
artikel
|
| 23 |
Plasmodium vivax: a roadblock on the quest to eliminate malaria
|
Cibulskis, Richard
|
|
2015
|
15 |
10 |
p. 1127-1128
|
artikel
|
| 24 |
Pregnancy-associated listeriosis: many beliefs, few facts
|
Elinav, Hila
|
|
2015
|
15 |
10 |
p. 1128-1130
|
artikel
|
| 25 |
Preparation for global introduction of inactivated poliovirus vaccine: safety evidence from the US Vaccine Adverse Event Reporting System, 2000–12
|
Iqbal, Shahed
|
|
2015
|
15 |
10 |
p. 1175-1182
|
artikel
|
| 26 |
Preventing infections in the most complex human organisation
|
Pittet, Didier
|
|
2015
|
15 |
10 |
p. 1144
|
artikel
|
| 27 |
Research brief
|
Bradbury, Jane
|
|
2015
|
15 |
10 |
p. 1142
|
artikel
|
| 28 |
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
|
Huttner, Angela
|
|
2015
|
15 |
10 |
p. 1156-1166
|
artikel
|
| 29 |
The Israeli public health response to wild poliovirus importation
|
Kaliner, Ehud
|
|
2015
|
15 |
10 |
p. 1236-1242
|
artikel
|
| 30 |
The LATTE study: a provocative brew
|
Boyd, Mark Alastair
|
|
2015
|
15 |
10 |
p. 1116-1117
|
artikel
|
| 31 |
The many shades of vaccine hesitancy
|
Burki, Talha
|
|
2015
|
15 |
10 |
p. 1138-1139
|
artikel
|
| 32 |
The prenylation inhibitor, lonafarnib: a new therapeutic strategy against hepatitis delta
|
Rizzetto, Mario
|
|
2015
|
15 |
10 |
p. 1119-1120
|
artikel
|
| 33 |
Threats to polio eradication in high-conflict areas in Pakistan and Nigeria: a polling study of caregivers of children younger than 5 years
|
SteelFisher, Gillian K
|
|
2015
|
15 |
10 |
p. 1183-1192
|
artikel
|
| 34 |
Towards genomic prediction of drug resistance in tuberculosis
|
Gardy, Jennifer L
|
|
2015
|
15 |
10 |
p. 1124-1125
|
artikel
|
| 35 |
Tuberculosis burden at post mortem
|
Hussain, Syed Ather
|
|
2015
|
15 |
10 |
p. 1133-1134
|
artikel
|
| 36 |
Tuberculosis burden at post mortem
|
Jain, Yogesh
|
|
2015
|
15 |
10 |
p. 1132-1133
|
artikel
|
| 37 |
Use of low dose rVSV-ZEBOV: safety issues in a Swiss cohort
|
Ledgerwood, Julie E
|
|
2015
|
15 |
10 |
p. 1117-1119
|
artikel
|
| 38 |
Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study
|
Walker, Timothy M
|
|
2015
|
15 |
10 |
p. 1193-1202
|
artikel
|
Tijdschrift beschrijving